A citation-based method for searching scientific literature

B B Biesecker, M Boehnke, K Calzone, D S Markel, J E Garber, F S Collins, B L Weber. JAMA 1993
Times Cited: 249







List of co-cited articles
725 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
598
45

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
32

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
26

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
23

Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
425
21

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
W Burke, M Daly, J Garber, J Botkin, M J Kahn, P Lynch, A McTiernan, K Offit, J Perlman, G Petersen,[...]. JAMA 1997
695
20

Psychological distress and surveillance behaviors of women with a family history of breast cancer.
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
430
18

Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.
K F Hoskins, J E Stopfer, K A Calzone, S D Merajver, T R Rebbeck, J E Garber, B L Weber. JAMA 1995
259
18

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
18

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
17

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
242
17


Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
15



Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
270
13

Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
262
13

A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing.
J R Botkin, R T Croyle, K R Smith, B J Baty, C Lerman, D E Goldgar, J M Ward, B J Flick, J E Nash. J Natl Cancer Inst 1996
77
16

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
912
13

Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
183
12

Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
345
12

Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.
G Geller, J R Botkin, M J Green, N Press, B B Biesecker, B Wilfond, G Grana, M B Daly, K Schneider, M J Kahn. JAMA 1997
156
12

A descriptive study of BRCA1 testing and reactions to disclosure of test results.
H T Lynch, S J Lemon, C Durham, S T Tinley, C Connolly, J F Lynch, J Surdam, E Orinion, S Slominski-Caster, P Watson,[...]. Cancer 1997
169
12


The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
138
11

Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
128
10

The impact of genetic counselling on risk perception in women with a family history of breast cancer.
D G Evans, V Blair, R Greenhalgh, P Hopwood, A Howell. Br J Cancer 1994
137
10


Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
10

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
R Wooster, S L Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, K Nguyen, S Seal, T Tran, D Averill. Science 1994
10

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
F J Couch, M L DeShano, M A Blackwood, K Calzone, J Stopfer, L Campeau, A Ganguly, T Rebbeck, B L Weber. N Engl J Med 1997
520
10


Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
C Lerman, C Hughes, R T Croyle, D Main, C Durham, C Snyder, A Bonney, J F Lynch, S A Narod, H T Lynch. Prev Med 2000
184
10

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
10


The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
345
9

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
S V Tavtigian, J Simard, J Rommens, F Couch, D Shattuck-Eidens, S Neuhausen, S Merajver, S Thorlacius, K Offit, D Stoppa-Lyonnet,[...]. Nat Genet 1996
661
9



BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
D Shattuck-Eidens, A Oliphant, M McClure, C McBride, J Gupte, T Rubano, D Pruss, S V Tavtigian, D H Teng, N Adey,[...]. JAMA 1997
287
8


Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
T S Frank, S A Manley, O I Olopade, S Cummings, J E Garber, B Bernhardt, K Antman, D Russo, M E Wood, L Mullineau,[...]. J Clin Oncol 1998
332
8



DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
H T Lynch, P Watson, T A Conway, J F Lynch, S M Slominski-Caster, S A Narod, J Feunteun, G Lenoir. Arch Intern Med 1993
91
7


Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991
388
7


The use and interpretation of commercial APC gene testing for familial adenomatous polyposis.
F M Giardiello, J D Brensinger, G M Petersen, M C Luce, L M Hylind, J A Bacon, S V Booker, R D Parker, S R Hamilton. N Engl J Med 1997
332
7

Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility.
J L Benkendorf, J E Reutenauer, C A Hughes, N Eads, J Willison, M Powers, C Lerman. Am J Med Genet 1997
74
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.